Vivaglobin and infusion site erythema Patient Reports February 11, 2012

Vivaglobin Side Effects Report #6090524-6
Vivaglobin side effect was reported by a Physician from UNITED STATES on Feb 06, 2009. Female patient, 64 years of age, weighting 175.0 lb, was diagnosed with immunodeficiency common variable and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: agitation, hypersensitivity, infusion site erythema, infusion site pruritus, musculoskeletal disorder, neurological symptom, type iv hypersensitivity reaction. Vivaglobin dosage: 46 ML Q1W SC; NI SC. During the same period patient was treated with PREVACID, COZAAR, ASPIRIN, METOPROLOL TARTRATE, XYZAL, ADVAIR HFA, ASMANEX TWISTHALER, SINGULAIR. Patient was hospitalized and became disabled. Patient recovered.

Vivaglobin Side Effects Report #5376709-2
Vivaglobin side effect was reported by a Physician from UNITED STATES on June 29, 2007. Female patient, 37 years of age, weighting 130.0 lb, was diagnosed with immunodeficiency common variable and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: infusion site erythema, infusion site pain, infusion site swelling. Vivaglobin dosage: unknown. Patient recovered.

Vivaglobin Side Effects Report #5636022-2
Vivaglobin side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2008. Female patient, weighting 245.0 lb, was diagnosed with immunodeficiency common variable and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: blood glucose increased, chest discomfort, dizziness , infusion related reaction, infusion site erythema, infusion site pruritus, wheezing. Vivaglobin dosage: unknown. Patient recovered.

Vivaglobin Side Effects Report #5087285-6
Vivaglobin side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2006. Male patient, 29 years of age, weighting 190.0 lb, was diagnosed with hypogammaglobulinaemia and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: dizziness , infusion related reaction, infusion site erythema, infusion site oedema, infusion site pruritus. Vivaglobin dosage: unknown. Patient recovered.


Vivaglobin Side Effects Report #5325023-X
Vivaglobin side effect was reported by a Pharmacist from UNITED STATES on May 11, 2007. Female patient, weighting 165.3 lb, was diagnosed with congenital hypogammaglobulinaemia and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: infusion site erythema, infusion site reaction, infusion site swelling, skin irritation. Vivaglobin dosage: 7.36 GRAMS -46 ML- EVERY 7 DAYS SQ. Patient recovered.

Vivaglobin Side Effects Report #5674540-1
Vivaglobin side effect was reported by a Physician from UNITED KINGDOM on Mar 04, 2008. Female patient, 45 years of age, weighting 232.4 lb, was diagnosed with combined immunodeficiency and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: abdominal distension, erysipelas, infusion site bruising, infusion site erythema, infusion site rash, injection site reaction, local reaction, migraine , rash erythematous. Vivaglobin dosage: 114 ML Q1W SC, 114 ML Q1W SC, 114 ML Q1W SC. During the same period patient was treated with PHYLLOCONTIN, QVAR, SEREVENT, ATROVENT, SALBUTAMOL, QUININE SULPHATE. Patient recovered.